There's a new pill for postpartum depression, but many at-risk women face hurdles • Stateline
$ 18.00 · 4.7 (199) · In stock
The first pill for postpartum depression approved by the U.S. Food and Drug Administration is now available, but experts worry that minority and low-income women, who are disproportionately affected by the condition, won’t have easy access to the new medication.
Nada Hassanein's Profile, Stateline Journalist
Friday, January 12, 2024 - KFF Health News
Miriam Y. Vega, PhD on LinkedIn: How record high temps are
Nada Hassanein, Author at New Jersey Monitor
FDA Approves New Postpartum Depression Pill
Policy Center for Maternal Mental Health on LinkedIn
Postpartum depression pill is safe and effective, new trial data shows
Postpartum depression: FDA approves fast-acting pill Zurzuvae
:max_bytes(150000):strip_icc()/Stocksy_comp_2054690-ee50522999044fb39ca029f34bf448c4.jpg)
The Postpartum Depression Pill Won't Solve America's Maternal Health Crisis
Health care Archives - Page 3 of 26 - Alabama Reflector